Hemostats Market Research Report – Forecast to 2023

Global Hemostats Market: Product Type (Thrombin Based, Collagen Based, Tissue Sealants- Fibrin Sealants, and Others), Instrument Type (Halstead Mosquito Hemostatic Forceps,), Application (Gynecology, Neurology, Cardiovascular) -–Global Forecast Till 2023

ID: MRFR/MED/4952-HCR | February 2021 | Region: Global | 100 pages

Market Scenario


The global hemostats market is expected to register a 6.4% growth during the forecast period (2018–2023).


Blood loss occurs in surgeries due to the damage of blood vessels. It is vital to coalesce the blood to avoid too much of blood loss. The formation of blood clots at the site of injury is called hemostasis. Hemostats are surgical tools that are used during surgeries to control the bleeding of the patient. These surgical instruments help to temporarily form blood clots to control bleeding. The hemostat is also known as a hemostatic clamp and arterial forceps. It is fundamentally used in the early phases of surgery for a preliminary incision that closes blood vessels till ligation.  Tissue sealants and tissue adhesion agents are very helpful for the application of hemostats.  


The growing number of surgical procedures, continuous progression in products range, rising incidences of sports-related damages, spinal disorders, technological advancements and increasing focus on effective blood loss management in patients during surgeries are the chief factors to boosts the hemostats market. Also, the emerging markets and rise in the number of hospitals and surgical centers are anticipated to offer added growth opportunities for players operating in the hemostats market. However, the high cost of hemostats, government’s rules and regulations and lack of skilled professionals is expected to hamper the growth of hemostats market.


Segmentation


The global hemostats market has been segmented on the basis of product type, instrument type, application, and end-user.


On the basis of product type, the market has been classified as thrombin-based, combination based, oxidized regenerated cellulose-based, gelatin based, collagen-based hemostat, tissue sealants, cyanoacrylate-based tissue adhesives, adhesion prevention products. The tissue sealants have been segmented into fibrin sealants, protein-based sealants.


On the basis of instrument type, the market has been classified as halstead mosquito hemostatic forceps, kelly and crile hemostatic forceps, and rochester-carmalt hemostatic forceps.


On the basis of application, the market has been classified as cardiovascular surgery, general surgery, gynecological surgery, reconstructive surgery, neurological surgery, orthopedic surgery, and other surgeries.


On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, community healthcare, and others.


On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.


The European hemostats market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The hemostats market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hemostats market in the Middle East and Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Hemostats Market Share, by Region, 2017 (%)


Hemostats Market Share


Source: MRFR Analysis


 In the hemostats market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. According to the National Health Statistics Report by the Centers of Disease Control & Prevention, in 2014, about 201,748.3 million surgical procedures were carried out in the U.S. The statistics also showed that 28.6 million appointments to ambulatory surgery cases were informed in the U.S.


 The European market is expected to hold the second largest market share. The market growth in this region can be attributed to growing frequency of cardiovascular disorders, increasing number of surgeries and rising demand for advanced treatment procedures are boosting the European market.


The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism.


The market in the Middle East and Africa is expected to account for the smallest share of the global hemostats market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global hemostats market are CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation(US).


Global Hemostats Market, by Product Type



  • Thrombin based

  • Combination-based

  • Oxidized regenerated cellulose based

  • Gelatin-based

  • Collagen-based hemostat

  • Tissue sealant

  • Fibrin sealants

  • Protein-based sealants

  • Cyanoacrylate-based tissue adhesives

  • Adhesion prevention products


Global Hemostats Market, by Instrument Type



  • Halstead mosquito hemostatic forceps

  • Kelly and Crile hemostatic forceps

  • Rochester-carmalt hemostatic forceps


Global Hemostats Market, by Application Type



  • Cardiovascular surgery

  • General surgery

  • Gynecological surgery

  • Reconstructive surgery

  • Neurological surgery

  • Orthopedic surgery

  • Other surgeries


Global Hemostats Market, by End-Users



  • Hospitals

  • Clinics

  • Ambulatory surgery centers

  • Community healthcare

  • Others


Global Hemostats Market, by Region



  • Americas

  • North America

  • US

  • Canada

  • South America

  • Europe

  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe

  • Asia-Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Middle East

  • Africa


Intended Audience



  • Advanced Surgical Trainees

  • Governmental Agency

  • Educational Organizations

  • Medical Device Manufacturers

  • Research Institutes and Academic Centers

  • Market Research and Consulting



Frequently Asked Questions (FAQ) :


Hemostats are surgical tools that are used during surgeries to control the bleeding of the patient.

The Hemostats Market is expected to exhibit a strong 6.4% CAGR over the forecast period from 2018 to 2023.

Growing number of surgical procedures around the world is the major driver for the hemostats market.

Americas hold the major share in the hemostats market, followed by Europe.

Leading players in the Hemostats Market include C.R. Bard, Stryker, and Pfizer, among others.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Hemostats Market, by Product Type

6.1 Introduction

6.2 Thrombin based

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3 Combination based

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.4 Oxidized regenerated cellulose based

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5 Gelatin based

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.6 Collagen-based

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023
6.7 Tissue sealant

6.7.1 Fibrin sealants

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.7.2 Protein-based sealants

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.8 Cyanoacrylate-based tissue adhesives

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.9 Adhesion prevention products

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 7. Global Hemostats Market, by Instrument Type

7.1 Introduction

7.2 Halstead mosquito hemostatic forceps

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 Kelly and Crile hemostatic forceps

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.4 Rochester-carmalt hemostatic forceps

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023
Chapter 8. Global Hemostats Market, by Application

8.1 Introduction

8.2 Cardiovascular surgery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3 General surgery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Gynecological surgery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.5 Reconstructive surgery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.6 Neurological surgery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.7 Orthopedic surgeries

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.8 Other surgeries

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 9. Global Hemostats Market, by End-Users

9.1 Introduction

9.2 Hospitals

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.3 Clinics

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.4 Ambulatory Surgery Centers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.5 Community healthcare

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.6 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 10. Global Hemostats Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 CR Bard, Inc.

12.1.1 Company Overview

12.1.2 Product Type Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 B. Braun Melsungen AG

12.2.1 Company Overview

12.2.2 Product Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Baxter International, Inc.

12.3.1 Company Overview

12.3.2 Product Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Integra LifeSciences

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Marine Polymer Technologies, Inc.

12.5.1 Company Overview

12.5.2 Product Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Teleflex

12.6.1 Company Overview

12.6.2 Product Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Ethicon, Inc.

12.7.1 Overview

12.7.2 Product Type Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Pfizer, Inc.

12.8.1 Overview

12.8.2 Product Type/ Technology Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Z-Medica LLC

12.9.1 Overview

12.9.2 Product Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Gelita Medical GmbH

12.10.1 Overview

12.10.2 Product Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.12 Anika Therapeutics, Inc.

12.12.1 Overview

12.12.2 Product Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.12 Stryker

12.12.1 Overview

12.12.2 Product Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Global Hemostats Market Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Hemostats Market Synopsis, 2018–2023

Table 2 Global Hemostats Market Estimates and Forecast, 2018–2023 (USD Million)

Table 3 Global Hemostats Market, by Region, 2018–2023 (USD Million)

Table 4 Global Hemostats Market, by Product Type, 2018–2023 (USD Million)

Table 5 Global Hemostats Market, by Instrument Type, 2018–2023 (USD Million)

Table 6 Global Hemostats Market, by Application, 2018–2023 (USD Million)

Table 7 Global Hemostats Market, by End-users, 2018–2023 (USD Million)

Table 8 North America: Global Hemostats Market, by Product Type, 2018–2023 (USD

Million)

Table 9 North America: Global Hemostats Market, by Instrument Type, 2018–2023 (USD

Million)

Table 10 North America: Global Hemostats Market, by Application, 2018–2023 (USD

Million)

Table 11 North America: Global Hemostats Market, by End-users, 2018–2023 (USD Million)

Table 12 US: Global Hemostats Market, by Product Type, 2018–2023 (USD Million)

Table 13 US: Global Hemostats Market, by Instrument Type, 2018–2023 (USD Million)

Table 14 US: Global Hemostats Market, by Application, 2018–2023 (USD Million)

Table 15 US: Global Hemostats Market, by End-users, 2018–2023 (USD Million)

Table 16 Canada: Global Hemostats Market, by Product Type, 2018–2023 (USD Million)

Table 17 Canada: Global Hemostats Market, by Instrument Type, 2018–2023 (USD Million)

Table 18 Canada: Global Hemostats Market, by Application, 2018–2023 (USD

Million)

Table 19 Canada Global Hemostats Market, by End-users, 2018–2023 (USD Million)

Table 20 South America: Global Hemostats Market, by Product Type, 2018–2023 (USD

Million)

Table 21 South America: Global Hemostats Market, by Instrument Type, 2018–2023 (USD

Million)

Table 22 South America: Global Hemostats Market, by Application, 2018–2023 (USD

Million)

Table 23 South America: Global Hemostats Market, by End-users, 2018–2023 (USD Million)

Table 24 Europe: Global Hemostats Market, by Product Type, 2018–2023 (USD Million)

Table 25 Europe: Global Hemostats Market, by Instrument Type, 2018–2023 (USD Million)

Table 26 Europe: Global Hemostats Market, by Application, 2018–2023 (USD Million)

Table 27 Europe: Global Hemostats Market, by End-users, 2018–2023 (USD Million)

Table 28 Western Europe: Global Hemostats Market, by Product Type, 2018–2023 (USD

Million)

Table 29 Western Europe: Global Hemostats Market, by Instrument Type, 2018–2023 (USD

Million)

Table 30 Western Europe: Global Hemostats Market, by Application, 2018–2023

(USD Million)

Table 31 Western Europe: Global Hemostats Market, by End-users, 2018–2023 (USD Million)

Table 32 Eastern Europe: Global Hemostats Market, by Product Type, 2018–2023 (USD

Million)

Table 33 Eastern Europe: Global Hemostats Market, by Instrument Type, 2018–2023 (USD

Million)

Table 34 Eastern Europe: Global Hemostats Market, by Application, 2018–2023

(USD Million)

Table 35 Eastern Europe: Global Hemostats Market, by End-users, 2018–2023 (USD Million)

Table 36 Asia-Pacific: Global Hemostats Market, by Product Type, 2018–2023 (USD

Million)

Table 37 Asia-Pacific: Global Hemostats Market, by Instrument Type, 2018–2023 (USD

Million)

Table 38 Asia-Pacific: Global Hemostats Market, by Application, 2018–2023 (USD

Million)

Table 39 Asia-Pacific: Global Hemostats Market, by End-users, 2018–2023 (USD Million)

Table 40 Middle East & Africa: Global Hemostats Market, by Product Type, 2018–2023

(USD Million)

Table 41 Middle East & Africa: Global Hemostats Market, by Instrument Type, 2018–2023

(USD Million)

Table 42 Middle East & Africa: Global Hemostats Market, by Application, 2018–2023

(USD Million)

Table 43 Middle East & Africa: Global Hemostats Market, by End-users, 2018–2023 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Hemostats Market

Figure 3 Segmentation Market Dynamics for Global Hemostats Market

Figure 4 Global Hemostats Market Share, by Product Type, 2017

Figure 5 Global Hemostats Market Share, by Instrument Type, 2017

Figure 6 Global Hemostats Market Share, by Application, 2017
Figure 7 Global Absorbable Surgical Sutures, by End-users, 2018–2023 (USD Million)

Figure 8 Global Hemostats Market Share, by Region, 2017

Figure 9 North America: Global Hemostats Market Share, by Country, 2017

Figure 10 Europe: Global Hemostats Market Share, by Country, 2017

Figure 11 Asia-Pacific: Global Hemostats Market Share, by Country, 2017

Figure 12 Middle East & Africa: Global Hemostats Market Share, by Country, 2017

Figure 13 Global Hemostats Market: Company Share Analysis, 2017 (%)

Figure 14 CR Bard, Inc.: Key Financials

Figure 15 CR Bard, Inc.: Segmental Revenue

Figure 16 CR Bard, Inc.: Geographical Revenue

Figure 17 B. Braun Melsungen AG: Key Financials

Figure 18 B. Braun Melsungen: Segmental Revenue

Figure 19 B. Braun Melsungen: Geographical Revenue

Figure 20 Baxter International, Inc.: Key Financials

Figure 21 Baxter International, Inc.: Segmental Revenue

Figure 22 Baxter International, Inc.: Geographical Revenue

Figure 23 Integra LifeSciences: Key Financials

Figure 24 Integra LifeSciences: Segmental Revenue

Figure 25 Integra LifeSciences: Geographical Revenue

Figure 26 Marine Polymer Technologies, Inc.: Key Financials

Figure 27 Marine Polymer Technologies, Inc.: Segmental Revenue

Figure 28 Marine Polymer Technologies, Inc.: Geographical Revenue

Figure 29 Teleflex: Key Financials

Figure 30 Teleflex: Segmental Revenue

Figure 31 Teleflex: Geographical Revenue

Figure 32 Ethicon, Inc.: Key Financials

Figure 33 Ethicon, Inc.: Segmental Revenue

Figure 34 Ethicon, Inc.: Geographical Revenue

Figure 35 Pfizer, Inc.: Key Financials

Figure 36 Pfizer, Inc.: Segmental Revenue

Figure 37 Pfizer, Inc.: Geographical Revenue

Figure 38 Z-Medica LLC: Key Financials

Figure 39 Z-Medica LLC: Segmental Revenue

Figure 40 Z-Medica LLC: Geographical Revenue

Figure 41 Gelita Medical GmbH: Key Financials

Figure 42 Gelita Medical GmbH: Segmental Revenue

Figure 43 Gelita Medical GmbH: Geographical Revenue

Figure 44 Anika Therapeutics, Inc.: Key Financials

Figure 45 Anika Therapeutics, Inc.: Segmental Revenue

Figure 46 Anika Therapeutics, Inc.: Geographical Revenue

Figure 47 Stryker: Key Financials

Figure 48 Stryker: Segmental Revenue

Figure 49 Stryker: Geographical Revenue